CoChat

Consequences and Determinants of Adherence to Antiretroviral Medication: Results from Adult Aids Clinical Trials Group Protocol 370

Open access
Ickovics, Jeannette R, Cameron, Ann, Zackin, Robert, Bassett, Roland, Chesney, Margaret, Johnson, Victoria A, Kuritzkes, Daniel R, ACTG 370 Protocol Team, Adult AIDS Clinical Trials Group protocol 370, Acosta, E, Barnett, R, Bell, D, Cannmann, S, Eron, J, Fischl, M, Marschner, I, Martinez, A, Morse, G, Pettinelli, C, Sommadossi, J-P, Wood, K, Murphy, R, Priller, N, Sha, B, French, N, van der Horst, C, Marcus, C, Lane, T, Horton, J, Schooley, R, Putnam, B, Shugarts, D, Johnson, S, Fife, K, Black, J, Heise, D, Todd, K, Bagur, JL Santana, Vazquez, GJ, Lopez, I, Ramirez, V, Hill, R, Wright, S, McCulloch, B, Saag, M, Slamowitz, D, Cain, P, Merigan, TC, Tallman, V, Greisberger, C, Shoemaker, M, Lewis, M, Hewitt, R, Havlir, D, Nuffer, K, Wininger, DA, Watson, S, Clark, J, Jackson, C, Rodriguez, A, Scerpella, E, Tebas, P, Stiffler, T, Royal, M, Powderly, WG, Collier, A, Storey, S, Houseworth, L, Conley, NJ, Lederman, M, Kalayjian, B, Ingersol, K, McVey, R, Gluckman, S, Helker, CP, Kappes, R, Kim, D, Albrecht, M, Koziol, C, Govan;, T, Miles, S, Chafey, S, Mitsuyasu, R, Sacks, H, Mildvan, D, Shikuma, C, Millard, M, Souza, S · 2002 · Antiviral Therapy
Cited by 128

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Objectives: (1) To document rates and patterns of adherence from enrollment until week 24 of an AIDS clinical trial; (2) to examine the association of adherence to clinical end-points including plasma HIV-1 RNA level and CD4 cell count; and (3) to identify predictors of adherence from clinical, behavioural, psychosocial and demographic factors. Design: Sub-study of a multicentre, randomised, open-label, comparison-controlled trial; 21 collaborating units of the Adult AIDS Clinical Trials Group. Observational, prospective analysis. Methods: Ninety-three subjects with baseline plasma HIV-1 RNA levels >500 copies/ml, who completed clinical assessment, plasma HIV-1 RNA titres and CD4 cell counts at study entry, weeks 2, 4 and every 4 weeks thereafter until week 24. All patients were antiretroviral-experienced but were naive to non-nucleoside reverse transcriptase inhibitors and protease inhibitors. Self-reported adherence to antiretroviral therapies prescribed as part of the trial was assessed every 4 weeks from trial, week 4 until week 24. Results: Average adherence was high, with 63% of subjects reporting >95% adherence across the trial. However, there was a significant decline in adherence over time on trial. After controlling for potential confounding variables, patients who were less than 95% adherent to medications were 3.5-times more likely to have treatment failure (HIV-1 RNA >50 copies/ml) than subjects with adherence rates of 95–100%. The strongest predictor of adherence was adverse clinical events (for example, dermatological, gastrointestinal symptoms): patients with adverse events were 12.8-times less likely to have 95–100% adherence. Other clinical, demographic, psychosocial and behavioural factors were also significant predictors of adherence. Conclusions: Adherence influences virological outcome even in AIDS clinical trials where overall adherence rates are high and should therefore be monitored in future trials. Intervention may be warranted to enhance adherence for subjects who have early toxicities, express concern about taking medications as directed, and for women and minorities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/135965350200700308

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 128

Metadata

Authors
Ickovics, J. R., Cameron, A., Zackin, R., Bassett, R., Chesney, M., Johnson, V. A., Kuritzkes, D. R., ACTG 370 Protocol Team, Adult AIDS Clinical Trials Group protocol 370, Acosta, E., Barnett, R., Bell, D., Cannmann, S., Eron, J., Fischl, M., Marschner, I., Martinez, A., Morse, G., Pettinelli, C., Sommadossi, J.-P., Wood, K., Murphy, R., Priller, N., Sha, B., French, N., van der Horst, C., Marcus, C., Lane, T., Horton, J., Schooley, R., Putnam, B., Shugarts, D., Johnson, S., Fife, K., Black, J., Heise, D., Todd, K., Bagur, J. S., Vazquez, G., Lopez, I., Ramirez, V, Hill, R., Wright, S., McCulloch, B., Saag, M., Slamowitz, D., Cain, P., Merigan, T., Tallman, V, Greisberger, C., Shoemaker, M., Lewis, M., Hewitt, R., Havlir, D., Nuffer, K., Wininger, D., Watson, S., Clark, J., Jackson, C., Rodriguez, A., Scerpella, E., Tebas, P., Stiffler, T., Royal, M., Powderly, W., Collier, A., Storey, S., Houseworth, L., Conley, N., Lederman, M., Kalayjian, B., Ingersol, K., McVey, R., Gluckman, S., Helker, C., Kappes, R., Kim, D., Albrecht, M., Koziol, C., Govan;, T., Miles, S., Chafey, S., Mitsuyasu, R., Sacks, H., Mildvan, D., Shikuma, C., Millard, M., & Souza, S.
Venue
Antiviral Therapy
Published
2002-04
Volume
7
Issue
3
Pages
185-193
ISSN
  • 1359-6535 (ISSN-L)
  • 2040-2058
OpenAlex
W914135345
Cited by
128
References
3
FWCI
5.01
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Consequences and Determinants of Adherence to Antiretroviral Medication: Results from Adult Aids Clinical Trials Group Protocol 370. https://app.cochat.ai/papers/10.1177/135965350200700308
The paper
Ickovics, J. R., Cameron, A., Zackin, R., Bassett, R., Chesney, M., Johnson, V. A., Kuritzkes, D. R., ACTG 370 Protocol Team, Adult AIDS Clinical Trials Group protocol 370, Acosta, E., Barnett, R., Bell, D., Cannmann, S., Eron, J., Fischl, M., Marschner, I., Martinez, A., Morse, G., Pettinelli, C., . . . Souza, S. (2002). Consequences and Determinants of Adherence to Antiretroviral Medication: Results from Adult Aids Clinical Trials Group Protocol 370. Antiviral Therapy. https://doi.org/10.1177/135965350200700308

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.